65,437 trials
Pharmacokinetics
Primary: Maximum Plasma Concentration (Cmax) — 2.43; 2.73; 3.69; 2.53 ng/mL
Healthy
Primary: Chronic Modulation of Cerebral Blood Flow — 0; 0 Participants — p=>0.05
Diabetes · Bladder Cancer
Primary: Incident Diagnosis of Bladder Cancer (10-year Analysis) — 89.8; 75.9 events per 100,000 person years
Painful Bladder Syndrome · Interstitial Cystitis
Primary: Chronic Prostatitis Symptom Index (CPSI-F) — 29.6; 35.2 Total CPSI-F
Diabetes
Primary: Fasting Endogenous Glucose Production (EGP) — 0.19; 1.59 umol per kg Fat-Free Mass (FFM) per min — p=<0.1
Chronic Lymphocytic Leukemia
Primary: Overall Objective Response — 3 participants who responded
Healthy Subjects
Primary: Percentage of Participants Achieving Serotype-specific Pneumococcal Immunoglobulin G (IgG) Antibody Level Greater Than or Equal to (>=) 0.35 Microgram Per Milliliter…
Healthy
Primary: Sleep Efficiency — 89.1; 83.3 percent
Obesity
Primary: Change From Baseline in High-sensitivity C-reactive Protein (hsCRP) at 6 Months — -0.37; -1.78; -0.29; 0.00 mg/dL
Human Papillomavirus Infection
Primary: Antibody Response to HPV Vaccine for HPV 6,11,16,18. — 1086.49; 1054.13; 745.06; 776.84 Milli Merck Units — p=>0.20
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 23.29; 24.11; 21.33; 18.53 Units on a scale — p=0.87
Gastroesophageal Reflux Disease (GERD)
Primary: The Percentage of Patients With Healing by Week 12 (Short-term Double-blind Treatment Phase) — 78; 83 Percentage of participants
Psoriasis
Primary: Percent Change From Baseline in Psoriasis Area and Severity Index (PASI) Score — 48.65; 75.70; 87.85; 90.29 Percent change
Scar Prevention · Scar Reduction
Primary: Differences Among the 3 Dosage Groups in the Patient (PSAS) and Observer (OSAS) Scar Assessment Scale (POSAS) Scores — 8.0; 8.0; 8.3; 6.8 Units on a scale — p=0.57
Pediculus Capitis Infestation
Primary: Efficacy of NatrOVA Creme Rinse - 1% Relative to NIX Creme Rinse in Subjects Infested With Head Lice — 72; 17; 36; 11 participants